About
About MyDeprescriber
MyDeprescriber.com helps people who want to come off psychiatric medication find clinicians who know how to do it slowly and safely — and trains those clinicians to a published standard.
Most prescribers were taught to stop antidepressants, benzodiazepines and Z-drugs over a few weeks. For a great many people that is far too fast, and the symptoms that follow get mistaken for the original condition returning. The result is a person who is told their illness came back when what actually happened is that their taper outran their nervous system.
We exist to close that gap from both ends: a public directory patients can search, and a certification that gives clinicians the method.
Who is behind this content
Lindsay Hill, DNP, PMHNP-BC is the clinical author behind MyDeprescriber’s guides and curriculum. Lindsay is a board-certified psychiatric mental health nurse practitioner who helps people taper psychiatric medications safely and on their own terms. Every patient guide and prescriber guide on this site is published under her byline.
MyDeprescriber.com, LLC is an Arizona limited liability company. It is an independent education and directory company. It is not a pharmaceutical company, is not owned by one, and accepts no pharmaceutical funding.
The method, and the evidence behind it
The approach we teach and look for is hyperbolic tapering — reducing a dose by a proportion of the current dose rather than by fixed increments, so the final, hardest milligrams come down in very small steps.
This is no longer a fringe position. The core principle — proportional rather than linear reductions — was adopted by the UK’s National Institute for Health and Care Excellence in 2022, which recommends reducing “in a step-wise fashion, at each step prescribing a proportion of the previous dose,” with smaller reductions as the dose gets lower. The pharmacological argument for it was set out by Mark Horowitz and David Taylor in The Lancet Psychiatry in 2019 and developed in The Maudsley Deprescribing Guidelines.
Where the evidence is genuinely contested — and parts of it are — we say so on the page rather than flattening it. Our guides cite their sources so you can read the underlying papers yourself.
- Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019;6(6):538–546. Link
- National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222). 2022. Link
- National Institute for Health and Care Excellence. Medicines associated with dependence or withdrawal symptoms (NG215). 2022. Link
- Royal College of Psychiatrists. Stopping antidepressants. Link
- Horowitz MA, Taylor D. The Maudsley Deprescribing Guidelines. Wiley, 2024. Link
What certification means here
A Provider listed as a Certified Deprescriber has completed The Deprescriber’s Playbook — a thirteen-module curriculum covering withdrawal pharmacology, tapering method, and the clinical judgement around stopping — and passed a proctored final examination. Certification lasts 24 months, after which it must be renewed.
Certification means a clinician has been trained to a standard and tested on it. It is not a licence, not a specialty board certification, and not a guarantee about any individual’s care. Licensure and credential verification remain the responsibility of the clinician and their state board, and we encourage you to verify both.
How we make money
We think you should know this before you use the directory. MyDeprescriber earns revenue two ways: clinicians pay to take the certification course, and clinicians may pay for a premium listing that gives their profile more prominence in search results.
Paid placement affects position and presentation in the directory. It does not affect whether someone can appear, and it is never presented as a clinical endorsement by us. Certification status is earned by passing the exam and cannot be bought.
What this site is not
Everything here is education, not medical advice, and it does not create a clinician–patient relationship. Please do not change or stop a psychiatric medication based on anything you read here. Stopping some of these medications abruptly can be dangerous. Bring what you learn to a prescriber who can supervise the change with you.
If you are in crisis, call or text 988 (US Suicide & Crisis Lifeline), or the SAMHSA National Helpline at 1-800-662-4357.
Corrections and contact
If you believe something on this site is inaccurate or out of date, tell us and we will look at it: hello@mydeprescriber.com. Our editorial policy explains how our content is researched, sourced and corrected.